Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

29.45INR
19 Oct 2018
Change (% chg)

Rs-0.85 (-2.81%)
Prev Close
Rs30.30
Open
Rs30.25
Day's High
Rs30.35
Day's Low
Rs28.40
Volume
2,530,635
Avg. Vol
3,071,914
52-wk High
Rs52.30
52-wk Low
Rs23.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 20 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 2,320.50 2,393.00 2,248.00 --
Year Ending Mar-18 1 9,520.00 9,520.00 9,520.00 --
Year Ending Mar-19 1 10,893.00 10,893.00 10,893.00 11,764.00
Year Ending Mar-20 1 13,155.00 13,155.00 13,155.00 --
Earnings (per share)
Year Ending Mar-18 1 1.30 1.30 1.30 --
Year Ending Mar-19 1 1.20 1.20 1.20 2.95
Year Ending Mar-20 1 1.70 1.70 1.70 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 2,390.00 2,352.53 37.47 1.57
Quarter Ending Mar-18 2,320.50 1,993.17 327.33 14.11
Quarter Ending Dec-17 2,758.00 2,188.22 569.78 20.66
Quarter Ending Sep-17 2,245.50 2,738.09 492.59 21.94
Quarter Ending Jun-17 1,958.50 2,210.56 252.06 12.87

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2,320.50 -- -- -- --
Year Ending Mar-18 9,520.00 -- -- -- --
Year Ending Mar-19 10,893.00 10,893.00 10,893.00 10,893.00 11,764.00
Year Ending Mar-20 13,155.00 13,155.00 13,155.00 13,155.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings